From the publisher feed
The use of menopause hormone therapy among women aged 40 to 74 rose from 2023 to 2026, suggests a study of a U.S. pharmacy database.
Read the original at Science News ↗Opens the original publisher page. Access, copyright and subscriptions are controlled by the publisher.
A useful next step
- Read the short publisher description here.
- Open the full report directly at the publisher.
- Compare this topic with other sources when useful.